These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1279473)

  • 1. The substance P (NK1) receptor antagonist (+/-)-CP-96,345 causes sedation and motor impairment in Swiss albino mice in the black-and-white box behavioral paradigm.
    Zernig G; Dietrich H; Maggi CA; Saria A
    Neurosci Lett; 1992 Aug; 143(1-2):169-72. PubMed ID: 1279473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different behavioral profiles of the non-peptide substance P (NK1) antagonists CP-96,345 and RP 67580 in Swiss albino mice in the black-and-white box.
    Zernig G; Troger J; Saria A
    Neurosci Lett; 1993 Mar; 151(1):64-6. PubMed ID: 7682312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of non-peptide tachykinin receptor antagonists to substantiate the involvement of NK1 and NK2 receptors in a spinal nociceptive reflex in the rat.
    Picard P; Boucher S; Regoli D; Gitter BD; Howbert JJ; Couture R
    Eur J Pharmacol; 1993 Mar; 232(2-3):255-61. PubMed ID: 7682180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antinociception induced by CP 96,345, a non-peptide NK-1 receptor antagonist, in the mouse formalin and capsaicin tests.
    Sakurada T; Katsumata K; Yogo H; Tan-No K; Sakurada S; Kisara K
    Neurosci Lett; 1993 Mar; 151(2):142-5. PubMed ID: 7685073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of antagonistic effects of sendide and CP-96,345 on a spinally mediated behavioural response in mice.
    Sakurada T; Manome Y; Katsumata K; Tan-No K; Sakurada S; Ohba M; Kisara K
    Eur J Pharmacol; 1994 Aug; 261(1-2):85-90. PubMed ID: 7528145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of NK1 tachykinin receptors in thermonociception: effect of (+/-)-CP 96,345, a non-peptide substance P antagonist, on the hot plate test in mice.
    Lecci A; Giuliani S; Patacchini R; Viti G; Maggi CA
    Neurosci Lett; 1991 Aug; 129(2):299-302. PubMed ID: 1720881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the nonpeptide NK-1 receptor antagonist CP-96,345 on the morphine withdrawal response of guinea-pigs.
    Chahl LA; Johnston PA
    Regul Pept; 1993 Jul; 46(1-2):373-5. PubMed ID: 7692540
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of 3,4-methylenedioxy-methamphetamine (MDMA) on anxiety in mice tested in the light-dark box.
    Maldonado E; Navarro JF
    Prog Neuropsychopharmacol Biol Psychiatry; 2000 Apr; 24(3):463-72. PubMed ID: 10836493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antagonism of substance P and related peptides by RP 67580 and CP-96,345, at tachykinin NK1 receptor sites, in the rat urinary bladder.
    Montier F; Carruette A; Moussaoui S; Boccio D; Garret C
    Eur J Pharmacol; 1994 Jan; 251(1):9-14. PubMed ID: 7511108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterisation of NK receptors in guinea-pig urinary bladder smooth muscle: use of selective antagonists.
    Longmore J; Hill RG
    Eur J Pharmacol; 1992 Nov; 222(1):167-70. PubMed ID: 1281775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of neurogenic plasma exudation in guinea-pig airways by CP-96,345, a new non-peptide NK1 receptor antagonist.
    Lei YH; Barnes PJ; Rogers DF
    Br J Pharmacol; 1992 Feb; 105(2):261-2. PubMed ID: 1373095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The substance P receptor antagonist CP-96,345 interacts with Ca2+ channels.
    Schmidt AW; McLean S; Heym J
    Eur J Pharmacol; 1992 Sep; 219(3):491-2. PubMed ID: 1385177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A potent nonpeptide antagonist of the substance P (NK1) receptor.
    Snider RM; Constantine JW; Lowe JA; Longo KP; Lebel WS; Woody HA; Drozda SE; Desai MC; Vinick FJ; Spencer RW
    Science; 1991 Jan; 251(4992):435-7. PubMed ID: 1703323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereospecific effects of a nonpeptidic NK1 selective antagonist, CP-96,345: antinociception in the absence of motor dysfunction.
    Yamamoto T; Yaksh TL
    Life Sci; 1991; 49(26):1955-63. PubMed ID: 1721102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opioid activity of sendide, a tachykinin NK1 receptor antagonist.
    Sakurada T; Yuhki M; Inoue M; Sakurada C; Tan-No K; Ohba M; Kisara K; Sakurada S
    Eur J Pharmacol; 1999 Mar; 369(3):261-6. PubMed ID: 10225361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different behavioral profiles of the non-peptide substance P (NK-1) antagonists CP-96,345 and RP 67580.
    Saria A; Troger J; Zernig G
    Regul Pept; 1993 Jul; 46(1-2):346-8. PubMed ID: 7692533
    [No Abstract]   [Full Text] [Related]  

  • 17. Ventilatory responses to hypoxia in rats pretreated with nonpeptide NK1 receptor antagonist CP-96,345.
    De Sanctis GT; Green FH; Jiang X; King M; Remmers JE
    J Appl Physiol (1985); 1994 Apr; 76(4):1528-32. PubMed ID: 7519186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of CP-96,345, a nonpeptide substance P receptor antagonist, on salivation in rats.
    Snider RM; Longo KP; Drozda SE; Lowe JA; Leeman SE
    Proc Natl Acad Sci U S A; 1991 Nov; 88(22):10042-4. PubMed ID: 1719543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity and distribution of binding sites in brain of a nonpeptide substance P (NK1) receptor antagonist.
    McLean S; Ganong AH; Seeger TF; Bryce DK; Pratt KG; Reynolds LS; Siok CJ; Lowe JA; Heym J
    Science; 1991 Jan; 251(4992):437-9. PubMed ID: 1703324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemokinin-1 mediates anxiolytic and anti-depressant-like actions in mice.
    Borbély É; Hajna Z; Nabi L; Scheich B; Tékus V; László K; Ollmann T; Kormos V; Gaszner B; Karádi Z; Lénárd L; Paige CJ; Quinn JP; Szolcsányi J; Pintér E; Keeble J; Berger A; Helyes Z
    Brain Behav Immun; 2017 Jan; 59():219-232. PubMed ID: 27621226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.